GW&K Investment Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $190K | Buy |
|
|||||
|
2025
Q1 | $193K | Sell |
|
|||||
|
2024
Q4 | $287K | Sell |
|
|||||
|
2024
Q3 | $1M | Sell |
|
|||||
|
2024
Q2 | $11.1M | Sell |
|
|||||
|
2024
Q1 | $13.6M | Buy |
|
|||||
|
2023
Q4 | $12M | Sell |
|
|||||
|
2023
Q3 | $17.4M | Sell |
|
|||||
|
2023
Q2 | $19.6M | Sell |
|
|||||
|
2023
Q1 | $30M | Buy |
|
|||||
|
2022
Q4 | $20.1M | Buy |
|
|||||
|
2022
Q3 | $11.5M | Buy |
|
|||||
|
2022
Q2 | $1.81M | Buy |
|
|||||
|
2022
Q1 | $2.44M | Buy |
|
|||||
|
2021
Q4 | $1.14M | Sell |
|
|||||
|
2021
Q3 | $1.05M | Buy |
|
|||||
|
2021
Q2 | $885K | Sell |
|
|||||
|
2021
Q1 | $714K | Buy |
|
|||||
|
2020
Q4 | $337K | Sell |
|
|||||
|
2020
Q3 | $25.1M | Sell |
|
|||||
|
2020
Q2 | $57.1M | Sell |
|
|||||
|
2020
Q1 | $53.5M | Buy |
|
|||||
|
2019
Q4 | $50.3M | Sell |
|
|||||
|
2019
Q3 | $48.8M | Sell |
|
|||||
|
2019
Q2 | $43.1M | Sell |
|
|||||
|
2019
Q1 | $38.5M | Buy |
|
|||||
|
2018
Q4 | $33.7M | Buy |
|
|||||
|
2018
Q3 | $41.6M | Sell |
|
|||||
|
2018
Q2 | $33.7M | Sell |
|
|||||
|
2018
Q1 | $30.4M | Sell |
|
|||||
|
2017
Q4 | $87.1M | Sell |
|
|||||
|
2017
Q3 | $92.2M | Buy |
|
|||||
|
2017
Q2 | $90.4M | Sell |
|
|||||
|
2017
Q1 | $82.2M | Sell |
|
|||||
|
2016
Q4 | $87M | Sell |
|
|||||
|
2016
Q3 | $82.6M | Sell |
|
|||||
|
2016
Q2 | $88.1M | Sell |
|
|||||
|
2016
Q1 | $81.8M | Buy |
|
|||||
|
2015
Q4 | $69.4M | Sell |
|
|||||
|
2015
Q3 | $64.1M | Buy |
|
|||||
|
2015
Q2 | $66.2M | Sell |
|
|||||
|
2015
Q1 | $70M | Sell |
|
|||||
|
2014
Q4 | $62.4M | Buy |
|
|||||
|
2014
Q3 | $51M | Buy |
|
|||||
|
2014
Q2 | $43.3M | Buy |
|
|||||
|
2014
Q1 | $43M | Buy |
|
|||||
|
2013
Q4 | $47.9M | Buy |
|
|||||
|
2013
Q3 | $39.1M | Buy |
|
|||||
|
2013
Q2 | $28.6M | Buy |
|